NCT04120246 2024-07-10Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast CancerVeana TherapeuticsPhase 1 Suspended24 enrolled
NCT02062983 2016-05-13Early Predictor of Herceptin Cardio Toxicity in Breast Cancer PatientsNational Guard Health AffairsSuspended50 enrolled